RISCC – RIsk-based Screening for Cervical Cancer

RISCC stands for “RIsk-based Screening for Cervical Cancer” and has received funding from the European Union’s Horizon2020 Framework Programme for Research and Innovation. RISCC is a multidisciplinary consortium of key researchers in the field of HPV, HPV screening, and HPV vaccination, which aims to develop and evaluate the first risk-based screening program for cervical cancer and provide open-source implementation tools, contributing to the elimination of cervical cancer in Europe.

A group of experts from 11 different institutions agreed on the conclusions of the 4-year project that we would like to share with our ENGAGe members and patients in different European countries.